Dutch diagnostics firm Qiagen has added to its recent acquisition of companion diagnostics expert DxS by purchasing PCR assay company SABiosciences. Qiagen, which is set to pay up to $130m for DxS, has agreed to spend a further $90m on SABiosciences in an all-cash deal. Frederick, ...
Please Login to read the full article.
